Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ying-Sheng Xiao"'
Autor:
Li-Yun Xie, Kun Wang, Hai-Lu Chen, Yan-Xia Shi, Yuan-Qi Zhang, Hao-Yu Lin, Yuan-Ke Liang, Ying-Sheng Xiao, Zhi-Yong Wu, Zhong-Yu Yuan, Si-Qi Qiu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPatients who achieve a tumor pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) have better outcomes than patients with residual tumor. However, tumors still recur in the pCR patients. Therefore, we aim to explore facto
Externí odkaz:
https://doaj.org/article/529ebebf407249008a4a9dc9b27a3c30
Autor:
Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Ying-sheng Xiao, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng, Hao-yu Lin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The chemokine CXCL9 (C-X-C motif chemokine ligand 9) has been reported to be required for antitumour immune responses following immune checkpoint blockade. In this study, we sought to investigate the potential value of CXCL9 according to immune respo
Externí odkaz:
https://doaj.org/article/cc1023860af3498388348b4727a9ac42
Autor:
Ying-Sheng Xiao, Yang Wu, De Zeng, Jing-Wen Bai, Xiao-Long Wei, Min Chen, Guo-Jun Zhang, Hao-Yu Lin, Yuan-Ke Liang
Publikováno v:
International Journal of Cancer, 147(2), 490-504. Wiley
Resistance to chemotherapy continues to be a critical issue in the clinical therapy of triple-negative breast cancer (TNBC). Epithelial-mesenchymal transition (EMT) is thought to contribute to chemoresistance in several cancer types, including breast
Autor:
Zhao-min XIE, Ying-sheng XIAO, Chun-yan XU, Qin XIE, Wen-de WANG, Zheng-hao WANG, Yuan-ke LIANG, Hao-yu LIN, De ZENG
Background: Breast cancer (BC) patients have a greater risk of developing thyroid cancer (TC) than the general population. Similarly, TC patients are more likely to develop BC, suggesting an underlying common etiology. In this study, we sought to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7333bff4dc45c84c3828522121290379
https://doi.org/10.21203/rs.3.rs-1162202/v1
https://doi.org/10.21203/rs.3.rs-1162202/v1
Autor:
De Zeng, Yang Wu, Yuan-Ke Liang, Guo-Jun Zhang, Yu-Zhu Qi, Xiao-Long Wei, Ying-Sheng Xiao, Wen-He Huang, Mei-Fang Li, Min Chen
Publikováno v:
Cancer letters, 440-441, 156-167. ELSEVIER IRELAND LTD
Resistance to chemotherapy remains a significant problem in the treatment of breast cancer, especially for triple negative breast cancer (TNBC), in which standard systemic therapy is currently limited to chemotherapeutic agents. Our study aimed to be
Autor:
Qin Xie, Ying-sheng XIAO, Shi-cheng JIA, Jie-xuan ZHENG, Zhen-chao DU, Yi-chun CHEN, Mu-tong CHEN, Yuan-ke LIANG, Hao-yu LIN, De Zeng
Background: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to predict th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::122be4ed62ba5bb08e8a371687b3884c
https://doi.org/10.21203/rs.3.rs-17365/v3
https://doi.org/10.21203/rs.3.rs-17365/v3
Autor:
Ying-Sheng Xiao, Jie-xuan Zheng, Zhen-chao Du, De Zeng, Shi-cheng Jia, Yi-chun Chen, Qin Xie, Mu-tong Chen, Yuan-Ke Liang, Hao-Yu Lin
Publikováno v:
Cancer Cell International
Background Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to predict the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08a3e8756a3d324672182f9706fd956
https://doi.org/10.21203/rs.3.rs-17365/v2
https://doi.org/10.21203/rs.3.rs-17365/v2
Autor:
Hao-Yu Lin, Yan-Xiu Ouyang, Min Chen, De Zeng, Yong-Qu Zhang, Yao-Chen Li, Xiao-Long Wei, Ying-Sheng Xiao, Frank A.E. Kruyt, Guo-Jun Zhang, Yuan-Ke Liang, Yang Wu
Publikováno v:
Cancer letters, 386, 65-76. ELSEVIER IRELAND LTD
Tamoxifen resistance presents a prominent clinical challenge in endocrine therapy for hormone sensitive breast cancer. However, the underlying mechanisms that contribute to tamoxifen resistance are not fully understood. In this study, we established
Autor:
Shaozhong Li, Mei-Fang Li, Min Chen, Ying-Sheng Xiao, Guo-Jun Zhang, De Zeng, Zun Wang, Hao-Yu Lin, Xiao-Long Wei, Yu-Zhu Qi
Publikováno v:
International Journal of Biological Sciences
Despite remarkable advancements in our understanding of breast cancer, it remains the leading cause of cancer deaths in women. Distant recurrence and metastasis is the main reason for death due to breast cancer. It is well recognized that the GATA bi
Publikováno v:
Cancer Management and Research
De Zeng,1,* Yingsheng Xiao,2,* Jianling Zhu,3 Chunyan Peng,4 Weiquan Liang,5 Haoyu Lin5 1Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515031, China; 2Department of Thyroid Surgery, Shantou Central Hos